en

PRODUCT DETAIL

Zulfija 0,03 mg/0,075 mg obalené tablety

Code 0875A
MA number 17/0163/12-S
Product Form: tbl obd 3x21 (blis.PVC/PVDC/Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 17 - ANTICONCIPIENTIA
ATC:
G GENITO URINARY SYSTEM AND SEX HORMONES
G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
G03AA Progestogens and estrogens, fixed combinations
G03AA10 Gestodene and ethinylestradiol(Gestodene and estrogen-delete WHO)
Shelf life: 36
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 26.04.2012
Pediatric posology: Yes
SPC: SPC_Zulfija 0,03 mg-0,075 mg obalené tablety_01.2022.pdf  
PIL: PIL_Zulfija 0,03 mg-0,075 mg obalené tablety_01.2022.pdf  
Safety feature Yes
Data update: 17.09.2019
eu-flag.png sk-flag.png